4.6 Article

TRAIL negatively regulates VEGF-induced angiogenesis via caspase-8-mediated enzymatic and non-enzymatic functions

Related references

Note: Only part of the references are listed.
Review Peripheral Vascular Disease

Tumour vasculature targeting agents in hybrid/conjugate drugs

E. M. Prokopiou et al.

ANGIOGENESIS (2013)

Article Cardiac & Cardiovascular Systems

Orai1 and CRAC Channel Dependence of VEGF-Activated Ca2+ Entry and Endothelial Tube Formation

Jing Li et al.

CIRCULATION RESEARCH (2011)

Review Oncology

Antiangiogenic therapy: impact on invasion, disease progression, and metastasis

John M. L. Ebos et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2011)

Article Biochemistry & Molecular Biology

Evidence that tumor necrosis factor-related apoptosis inducing ligand (TRAIL) inhibits angiogenesis by inducing vascular endothelial cell apoptosis

Pei-Lin Chen et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)

Article Cell Biology

Chronic morphine treatment inhibits LPS-induced angiogenesis: Implications in wound healing

Josephine L. Martin et al.

CELLULAR IMMUNOLOGY (2010)

Article Medicine, Research & Experimental

Endothelial FAK is required for tumour angiogenesis

Bernardo Tavora et al.

EMBO MOLECULAR MEDICINE (2010)

Review Cell Biology

From Procaspase-8 to Caspase-8: Revisiting Structural Functions of Caspase-8

Yang Zhao et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2010)

Article Hematology

Caspase-8 Is Involved in Neovascularization-Promoting Progenitor Cell Functions

Doerte Scharner et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)

Article Oncology

Critical Role for Caspase-8 in Epidermal Growth Factor Signaling

Darren Finlay et al.

CANCER RESEARCH (2009)

Review Oncology

TRAIL receptor signalling and modulation: Are we on the right TRAIL?

Devalingam Mahalingam et al.

CANCER TREATMENT REVIEWS (2009)

Review Oncology

Targeting PI3K signalling in cancer: opportunities, challenges and limitations

Jeffrey A. Engelman

NATURE REVIEWS CANCER (2009)

Article Biochemistry & Molecular Biology

Blockade of processing/activation of caspase-3 by hypoxia

Sang Hee Han et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)

Review Pharmacology & Pharmacy

Non-apoptotic functions of caspase-8

Jonathan Maelfait et al.

BIOCHEMICAL PHARMACOLOGY (2008)

Review Pharmacology & Pharmacy

TRAIL receptor-targeted therapeutics: Resistance mechanisms and strategies to avoid them

Andrew Thorburn et al.

DRUG RESISTANCE UPDATES (2008)

Article Biochemistry & Molecular Biology

Identification of a critical tyrosine residue in caspase 8 that promotes cell migration

Simone Barbero et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Article Cardiac & Cardiovascular Systems

Fractalkine stimulates angiogenesis by activating the Raf-1/MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways

Seon-Jin Lee et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)

Article Oncology

TRAIL inhibits angiogenesis stimulated by VEGF expression in human glioblastoma cells

G. Cantarella et al.

BRITISH JOURNAL OF CANCER (2006)

Article Biochemistry & Molecular Biology

Src kinase phosphorylates caspase-8 on Tyr380:: a novel mechanism of apoptosis suppression

Silvia Cursi et al.

EMBO JOURNAL (2006)

Review Biotechnology & Applied Microbiology

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

N Ferrara et al.

NATURE REVIEWS DRUG DISCOVERY (2004)

Article Ophthalmology

Focal adhesion kinase overexpression induces enhanced pathological retinal angiogenesis

LJ Kornberg et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)

Review Oncology

Angiogenesis-dependent diseases

J Folkman

SEMINARS IN ONCOLOGY (2001)

Letter Biochemistry & Molecular Biology

Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

D Lawrence et al.

NATURE MEDICINE (2001)